MedTech Europe responds to the call for evidence on Antimicrobial Resistance
Posted on 06.04.2022
MedTech Europe has responded to a recent call for evidence for an initiative on “Antimicrobial resistance – recommendation for greater action.” The European Commission has launched the call, and the results will feed in a Council Recommendation to be issued in late 2022. AMR is a cross-border and cross-cutting issue, it affects human, animal and environmental health. The EU has different competencies across the ‘one health’ spectrum. For this reason, a Council recommendation on AMR will make it possible to address the full range in a coherent and practical framework. In particular, the call for evidence aims at setting concrete objectives and activities to strengthen Member States’ action against AMR, mainly in the area of public health, where the EU has only supporting and complementary competence.
In response to the call for evidence, MedTech Europe highlighted how the effective use of diagnostic tests and medical devices could be part of the solution in fighting AMR caused by the over-and misuse of antibiotics and the spread of resistant strains. Also, some policy recommendations were provided, such as the need for a harmonised approach to Infection Prevention & Control (IPC) at the European level. Moreover, the Association asked for a broader implementation of antimicrobial stewardship programmes across all health care settings and better preparedness for future pandemics, including the spread of AMR.
If you wish to receive more information, please contact Miriam D’Ambrosio, Manager Communications.